ProQR Therapeutics
-$0.04 (-0.59%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell PRQR and other stocks, options, and ETFs commission-free!
About PRQR
ProQR Therapeutics N.V. Ordinary Shares, also called ProQR Therapeutics, is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa.
CEO
Daniel Anton de Boer
Employees
150
Headquarters
Leiden, Zuid-Holland
Founded
2012
PRQR Key Statistics
Market Cap
432.98M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
484.20K
High Today
$6.85
Low Today
$6.58
Open Price
$6.69
Volume
397.61K
52 Week High
$9.46
52 Week Low
$3.40
Analyst Ratings
100%
of 8 ratings
Buy
100%
Hold
0%
Sell
0%
PRQR Earnings
-$0.43
-$0.29
-$0.14
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market